Pharma Foods International (2929) · RiskFirst stated

Reliance on PharmaGABA Sales in the Functional Ingredients Business

First written in FY2021. . Latest entry: FY2021.

1entries

1years

0from disclosures

Share on X

How it moved

Same theme, other companies

Revenue dependence on flagship product Cuenote FCA theme 78 companies write about · 79 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 12 of 47 companies on the "Worse" side.

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 78 companies compared. The sentences above are computed from all 78.

Full recordFilings, disclosures and news, newest first

FY2021First statedAnnual report
「“PharmaGABAⓇ” accounted for 47.3% of segment sales, and its impact on segment performance is increasing.」
PharmaGABA accounted for 47.3% of functional materials business sales, and the company disclosed increasing dependence on the product as an issue.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for Pharma Foods International yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.